Fisher Scientific Expands its Biopharma Services Offering; Company to Acquire Clintrak Pharmaceutical Services

The acquisition of Clintrak Pharmaceutical will not only enhanceFisher's existing biopharma services offering, which includes a fullrange of clinical-trial materials, logistics, analytical testing andbio-specimen management services, but also add complementary expertisein the area of complex clinical-trial labeling services. The Clintrakacquisition is expected to close early in the second quarter.

Fisher also announced that it has acquired privately held TC Tech,a leading provider of single-use, flexible bioprocessing systems forbioprocess development and production applications. TC Tech's productsinclude sterile fluid-handling bags, bag manifold systems, tanks andtank liners, biopharmaceutical tubing and other components. Togetherwith Fisher's HyClone operation, TC Tech will provide Fisher with anextensive suite of disposable fluid- management systems and validatedserum and media offerings for its biopharma customers.

Fisher is funding the acquisitions with cash-on-hand and bankborrowings. The company expects the acquisitions will have no effecton its 2006 earnings per share and that they will be accretive in2007.

About Clintrak Pharmaceutical Services

Clintrak Pharmaceutical Services is a leading provider ofclinical-trial printing services, including single panel label andbooklet label design and production, to pharmaceutical andbiotechnology companies worldwide. The company's booklet labelservices offer customers an accurate and cost-effective method ofproviding labels for global, multi-lingual clinical trials. Along withits wholly owned subsidiary, Acculogix, the company also providesclinical-trial materials and supply-chain management services for allstages of a clinical trial.

About TC Tech

TC Tech is a global supplier of sterile fluid-handling bags andrelated fluid transfer components to the biopharmaceuticalmanufacturing market. The company offers innovative technologies thatmaximize the utility and application base of single-use products. TCTech has representation in more than 100 countries and works on sitewith customers to optimize the design of disposable fluid-handlingsystems.

Fisher Scientific: A World Leader in Serving Science

Fisher Scientific International Inc. (NYSE: FSH) is a leadingprovider of products and services to the scientific community. Fisherfacilitates discovery by supplying researchers and clinicians in labsaround the world with the tools they need. We serve pharmaceutical andbiotech companies; colleges and universities; medical-researchinstitutions; hospitals; reference, quality-control, process-controland R&D labs in various industries; as well as government agencies.From biochemicals, cell-culture media and proprietary RNAi technologyto rapid-diagnostic tests, safety products and other consumablesupplies, Fisher provides more than 600,000 products and services.This broad offering, combined with Fisher's globally integrated supplychain and unmatched sales and marketing capabilities, helps make our350,000 customers more efficient and effective at what they do.

Founded in 1902, Fisher Scientific is a FORTUNE 500 company and isa component of the S&P 500 Index. With approximately 19,500 employeesworldwide, the company had revenues of $5.6 billion in 2005. FisherScientific is a company committed to delivering on our promises -- tocustomers, shareholders and employees alike. Additional informationabout Fisher is available on the company's Web site atwww.fisherscientific.com

About Bear Growth Capital Partners

Bear Growth Capital Partners (BGCP) is an affiliate of BearStearns Merchant Banking, the private equity arm of the Bear StearnsCompanies Inc. (NYSE:BSC). BGCP focuses on making investments inmiddle market companies valued between $20 and $100 million. BGCPinvests in compelling growth capital opportunities, traditionalbuyouts, recapitalizations, co-investments, and control and minorityownership positions alongside superior management teams and otherprivate equity sponsors. More information about BGCP can be found atwww.bsmb.com.

Forward-looking Statements

This announcement includes "forward-looking statements" within themeaning of the Private Securities Litigation Reform Act of 1995. Allsuch statements are based on current expectations and projectionsabout future events. No assurances can be given that FisherScientific's assumptions and expectations will prove to have beencorrect, and actual results could vary materially from theseassumptions and expectations. Important factors that could causeactual results to differ materially from the results predicted includechallenges presented by our acquisitions; economic and political risksrelated to our international operations; changes in the healthcareindustry; the impact of government regulation; dependence on ourcustomers' research and development efforts; and changes ordisruptions in our relationships with our customers, suppliers and keyemployees, together with other potential risks and uncertainties, allof which are detailed under the captions "Risk Factors" and"Management's Discussion and Analysis of Financial Condition andResults of Operations" in Fisher Scientific's annual reports on Form10-K and its other filings with the Securities and ExchangeCommission. Copies of such reports are available on FisherScientific's Web site at www.fisherscientific.com and on the SEC's Website at www.sec.gov. Fisher Scientific undertakes no obligation topublicly update or revise any forward-looking statements, whether as aresult of new information, future events or otherwise.